Anu Gupta

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants

Bryan D. Smith, Michael D. Kaufman, Wei-Ping Lu et al. · Cancer Cell · 2019 · 277 citations

Medicine, Oncology, Pharmacology +17

Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST)

Anu Gupta, Srirupa Roy, Alexander J. Lazar et al. · Proceedings of the National Academy of Sciences · 2010 · 212 citations

Life Sciences, Oncology, Pharmacology +17

Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.

Anu Gupta, Andrew K. Godwin, Lisa Vanderveer et al. · PubMed · 2003 · 185 citations

Life Sciences, Genetics, Oncology +17

Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial

Pascal Hammel, Fabienne Portales, Laurent Mineur et al. · European Journal of Cancer · 2019 · 109 citations · Full text

Medicine, Oncology, Pharmacology +9

Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1

Anu Gupta, Satoru Inaba, Oi Kwan Wong et al. · Oncogene · 2003 · 104 citations

Life Sciences, Genetics, Molecular Biology +11